The cationic cell‐penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells
The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated...
Saved in:
Published in | Journal of cellular physiology Vol. 234; no. 12; pp. 22116 - 22129 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.12.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9541 1097-4652 1097-4652 |
DOI | 10.1002/jcp.28774 |
Cover
Abstract | The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan‐rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin‐mediated and caveolae‐mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2‐treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis‐inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy‐related 5, autophagy‐related 7, autophagy‐related 16 like 1, and Beclin‐1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells.
Our findings showed that KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression. |
---|---|
AbstractList | The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan-rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin-mediated and caveolae-mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2-treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis-inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy-related 5, autophagy-related 7, autophagy-related 16 like 1, and Beclin-1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells.The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan-rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin-mediated and caveolae-mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2-treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis-inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy-related 5, autophagy-related 7, autophagy-related 16 like 1, and Beclin-1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells. The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan‐rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin‐mediated and caveolae‐mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2‐treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis‐inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy‐related 5, autophagy‐related 7, autophagy‐related 16 like 1, and Beclin‐1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells. The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan‐rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin‐mediated and caveolae‐mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2‐treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis‐inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy‐related 5, autophagy‐related 7, autophagy‐related 16 like 1, and Beclin‐1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells. The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer cells. However, their antitumor properties and underlying mechanisms in cancer cells have not been clearly understood. In this study, we evaluated the effects of KT2 (lysine/tryptophan‐rich AMP) on the cellular uptake and internalization mechanism, cell viability, surface charge of the cell membrane, membrane integrity, apoptotic cell death, and autophagy in human HCT 116 colon cancer cells. We found that KT2 interacted with the cell membrane of HCT 116 cells and was internalized into HCT 116 cells via clathrin‐mediated and caveolae‐mediated endocytosis mechanisms. The interaction of KT2 with cells caused cell membrane structure change, elevated membrane permeability, and KT2 also affected the lipid component. The results of atomic force microscopy showed cellular membrane defects of KT2‐treated cells. The internalized KT2 induced nuclear condensation and apoptotic cell death. It elevated the apoptotic factor levels including those of cytochrome c and apoptosis‐inducing factor. Furthermore, KT2 inhibited autophagy by the suppression of autophagy‐related 5, autophagy‐related 7, autophagy‐related 16 like 1, and Beclin‐1 proteins. In conclusion, these results revealed the cytotoxicity of cationic KT2 against HCT 116 cells and may help to clarify the interactions between cationic AMPs and cancer cells. Our findings showed that KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression. |
Author | Klaynongsruang, Sompong Boonsiri, Patcharee Daduang, Sakda Maraming, Pornsuda Daduang, Jureerut Leelayuwat, Chanvit Peng, Shu‐Fen Pientong, Chamsai Chung, Jing‐Gung |
Author_xml | – sequence: 1 givenname: Pornsuda surname: Maraming fullname: Maraming, Pornsuda organization: Khon Kaen University – sequence: 2 givenname: Sompong surname: Klaynongsruang fullname: Klaynongsruang, Sompong organization: Khon Kaen University – sequence: 3 givenname: Patcharee surname: Boonsiri fullname: Boonsiri, Patcharee organization: Khon Kaen University – sequence: 4 givenname: Shu‐Fen surname: Peng fullname: Peng, Shu‐Fen organization: China Medical University Hospital – sequence: 5 givenname: Sakda surname: Daduang fullname: Daduang, Sakda organization: Khon Kaen University – sequence: 6 givenname: Chanvit surname: Leelayuwat fullname: Leelayuwat, Chanvit organization: Khon Kaen University – sequence: 7 givenname: Chamsai surname: Pientong fullname: Pientong, Chamsai organization: Khon Kaen University – sequence: 8 givenname: Jing‐Gung surname: Chung fullname: Chung, Jing‐Gung email: jgchung@mail.cmu.edu.tw organization: China Medical University – sequence: 9 givenname: Jureerut orcidid: 0000-0003-0977-4144 surname: Daduang fullname: Daduang, Jureerut email: jurpoo@kku.ac.th organization: Khon Kaen University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31073999$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1u1DAQxy3Uim4LB14AWeICh7T-SNbxEa2AQivBYTlbjj1pvErsEDuq9tZH6IkH5EnwfvRSgS-2xr_5z8x_ztGJDx4QekPJJSWEXW3MeMlqIcoXaEGJFEW5rNgJWuQ_WsiqpGfoPMYNIURKzl-iM06J4FLKBfq97gAbnVzwzmADff_n4XEED2nKQX-Hb9YMjzAmZwGPUxhCgrjn8ABDM2kP2EILJkWsvcV6DGMK0UV871KH9ZzC2Om7LXa-c43b1clP3M2D9vh6tcaULrEJfQ4b7Q1Me-34Cp22uo_w-nhfoJ-fP61X18Xt9y9fVx9vC8MrXhaUA9GytGAZrQgRpmoba4nWnNvaLtu6kW0-ogEpWWstq9tSN4aWFRGS1w2_QO8Punm0XzPEpAYXdx3kucIcFWOcyopWlGX03TN0E-bJ5-4yJWR2X3CaqbdHam4GsGqc3KCnrXpyPANXB8BMIcYJWmVc2vufHXe9okTtdqryTtV-pznjw7OMJ9F_sUf1e9fD9v-g-rb6ccj4C7mssvI |
CitedBy_id | crossref_primary_10_1016_j_ejps_2022_106336 crossref_primary_10_3390_toxins14070438 crossref_primary_10_1039_D1TB02134F crossref_primary_10_1016_j_tiv_2021_105212 crossref_primary_10_1007_s10989_024_10602_0 crossref_primary_10_1002_tox_23864 crossref_primary_10_1021_acsomega_1c02569 crossref_primary_10_1186_s40779_021_00343_2 crossref_primary_10_3390_molecules25235778 crossref_primary_10_1111_cbdd_70018 crossref_primary_10_1021_acs_molpharmaceut_2c00359 crossref_primary_10_2147_IJN_S445333 crossref_primary_10_1007_s00210_023_02536_z crossref_primary_10_1021_acsabm_1c00390 crossref_primary_10_1002_tox_23993 crossref_primary_10_1021_acs_jnatprod_1c00963 crossref_primary_10_1038_s41392_024_02035_4 crossref_primary_10_3389_fmicb_2022_879207 crossref_primary_10_1093_bbb_zbab153 crossref_primary_10_1016_j_bbcan_2024_189197 crossref_primary_10_1016_j_bbamem_2020_183447 crossref_primary_10_1016_j_ejcb_2022_151223 crossref_primary_10_3390_ijms242316718 crossref_primary_10_1111_1440_1681_13524 crossref_primary_10_3390_ijms22158231 crossref_primary_10_3390_jfb14110539 crossref_primary_10_1039_D1CP01326B crossref_primary_10_1039_D1RA05980G |
Cites_doi | 10.3390/Ijms17030332 10.1016/j.bbagen.2012.02.015 10.1007/s00018‐017‐2604‐z 10.1021/acs.jmedchem.5b01264 10.1016/j.bbamem.2007.11.008 10.1074/jbc.C400051200 10.1016/j.bbamem.2012.06.006 10.1002/tox.22108 10.18632/oncotarget.16743 10.1128/CDLI.8.6.1131‐1135.2001 10.1038/S41598‐017‐02227‐9 10.1042/BJ20061100 10.3389/fchem.2017.00005 10.1096/fj.201600811R 10.1186/s12906‐015‐0940‐9 10.1016/j.etap.2018.07.007 10.1186/S12935‐018‐0646‐4 10.1021/acs.jmedchem.5b02016 10.1038/s41598‐017‐08963‐2 10.1016/j.ymthe.2005.03.038 10.2147/OTT.S100685 10.1002/jcp.25958 10.1016/j.febslet.2015.11.002 10.1016/j.bbamem.2016.06.025 10.1016/j.biomaterials.2013.10.082 10.1038/Srep11719 10.1007/s00726‐012‐1421‐9 10.1016/j.ijantimicag.2008.04.003 10.1016/j.bbamcr.2014.11.006 10.1007/s00726‐017‐2453‐y 10.3390/ijms17050701 10.1371/journal.pone.0126390 10.3892/ol.2016.4601 10.1371/journal.pone.0063641 10.1371/journal.pone.0057236 10.3389/fnins.2017.00073 10.3390/bios7040057 10.1016/j.cbpa.2017.03.014 10.3892/ijo.2017.3866 10.1002/smll.200900520 10.1007/s11274‐015‐1986‐z 10.1016/j.jinorgbio.2017.07.011 10.1002/tox.22568 10.1016/j.yexcr.2007.05.015 10.1158/1535‐7163.MCT‐04‐0077 10.1021/acsmedchemlett.5b00433 10.1016/j.bmcl.2013.06.005 10.1039/c7ob02233f 10.2147/IJN.S109795 10.1093/humupd/dmu065 10.18632/oncotarget.22890 10.1155/2015/735087 10.1016/j.bbamem.2014.11.013 10.1093/emboj/cdg423 10.4014/jmb.1411.11058 10.1016/j.ejphar.2009.08.043 |
ContentType | Journal Article |
Copyright | 2019 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION NPM 7TK 7U7 8FD C1K FR3 K9. P64 RC3 7X8 |
DOI | 10.1002/jcp.28774 |
DatabaseName | CrossRef PubMed Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Genetics Abstracts CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Biology |
EISSN | 1097-4652 |
EndPage | 22129 |
ExternalDocumentID | 31073999 10_1002_jcp_28774 JCP28774 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: The Royal Golden Jubilee (RGJ) Ph.D. Scholarship funderid: PHD/0014/2558 – fundername: Khon Kaen University funderid: 61004605 – fundername: Synchrotron Light Research Institute funderid: 2559‐KKU‐SLRI‐01–09 – fundername: China Medical University, Taichung, Taiwan funderid: CMU107‐ASIA‐17 – fundername: Khon Kaen University (Synchrotron Light Research Institute ) funderid: grant no. 2559‐KKU‐SLRI‐01‐09 – fundername: National Research Council of Thailand funderid: grant no. 2558; 2558 |
GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 9M8 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDPE ABEFU ABEML ABIJN ABJNI ABPPZ ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BQCPF BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ H~9 IH2 IX1 J0M JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M56 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NEJ NF~ NNB O66 O9- OHT OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RWR RX1 RYL S10 SAMSI SUPJJ SV3 TN5 TWZ UB1 UPT V2E V8K VQP W8V W99 WBKPD WH7 WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WXSBR WYB WYISQ X7M XG1 XJT XOL XPP XSW XV2 Y6R YQT YZZ ZGI ZXP ZZTAW ~IA ~WT AAYXX ADXHL AETEA AEYWJ AGHNM AGQPQ AGYGG CITATION NPM PKN 7TK 7U7 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3534-13e0a94ded215007c5fbdd0aa33d8d6f8b9ffff7be992fdd28f4abc14507938b3 |
IEDL.DBID | DR2 |
ISSN | 0021-9541 1097-4652 |
IngestDate | Fri Jul 11 11:24:56 EDT 2025 Fri Jul 25 22:43:56 EDT 2025 Wed Feb 19 02:30:48 EST 2025 Tue Jul 01 01:32:03 EDT 2025 Thu Apr 24 22:53:02 EDT 2025 Wed Jan 22 16:38:59 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | cationic cell-penetrating KT2 apoptosis autophagy antimicrobial peptide membrane permeability |
Language | English |
License | 2019 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3534-13e0a94ded215007c5fbdd0aa33d8d6f8b9ffff7be992fdd28f4abc14507938b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0977-4144 |
PMID | 31073999 |
PQID | 2279774731 |
PQPubID | 1006363 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2231951512 proquest_journals_2279774731 pubmed_primary_31073999 crossref_citationtrail_10_1002_jcp_28774 crossref_primary_10_1002_jcp_28774 wiley_primary_10_1002_jcp_28774_JCP28774 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2019 2019-12-00 20191201 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cellular physiology |
PublicationTitleAlternate | J Cell Physiol |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_9_1_15_1 e_1_2_9_1_36_1 e_1_2_9_1_13_1 e_1_2_9_1_34_1 e_1_2_9_1_11_1 e_1_2_9_1_32_1 e_1_2_9_1_30_1 e_1_2_9_1_2_1 e_1_2_9_1_4_1 e_1_2_9_1_6_1 e_1_2_9_1_29_1 e_1_2_9_1_27_1 e_1_2_9_1_25_1 e_1_2_9_1_48_1 e_1_2_9_1_23_1 e_1_2_9_1_46_1 e_1_2_9_1_21_1 e_1_2_9_1_44_1 e_1_2_9_1_42_1 e_1_2_9_1_40_1 e_1_2_9_1_8_1 e_1_2_9_1_50_1 e_1_2_9_1_52_1 e_1_2_9_1_54_1 e_1_2_9_1_18_1 e_1_2_9_1_56_1 e_1_2_9_1_16_1 e_1_2_9_1_39_1 e_1_2_9_1_14_1 e_1_2_9_1_37_1 e_1_2_9_1_12_1 e_1_2_9_1_35_1 e_1_2_9_1_10_1 e_1_2_9_1_33_1 e_1_2_9_1_31_1 e_1_2_9_1_3_1 e_1_2_9_1_5_1 e_1_2_9_1_28_1 e_1_2_9_1_49_1 e_1_2_9_1_26_1 e_1_2_9_1_47_1 e_1_2_9_1_24_1 e_1_2_9_1_45_1 e_1_2_9_1_22_1 e_1_2_9_1_43_1 e_1_2_9_1_20_1 e_1_2_9_1_41_1 e_1_2_9_1_7_1 e_1_2_9_1_9_1 e_1_2_9_1_51_1 e_1_2_9_1_53_1 e_1_2_9_1_55_1 e_1_2_9_1_19_1 e_1_2_9_1_57_1 e_1_2_9_1_17_1 e_1_2_9_1_38_1 |
References_xml | – ident: e_1_2_9_1_31_1 doi: 10.3390/Ijms17030332 – ident: e_1_2_9_1_41_1 doi: 10.1016/j.bbagen.2012.02.015 – ident: e_1_2_9_1_6_1 doi: 10.1007/s00018‐017‐2604‐z – ident: e_1_2_9_1_25_1 doi: 10.1021/acs.jmedchem.5b01264 – ident: e_1_2_9_1_22_1 doi: 10.1016/j.bbamem.2007.11.008 – ident: e_1_2_9_1_40_1 doi: 10.1074/jbc.C400051200 – ident: e_1_2_9_1_3_1 doi: 10.1016/j.bbamem.2012.06.006 – ident: e_1_2_9_1_42_1 doi: 10.1002/tox.22108 – ident: e_1_2_9_1_15_1 doi: 10.18632/oncotarget.16743 – ident: e_1_2_9_1_39_1 doi: 10.1128/CDLI.8.6.1131‐1135.2001 – ident: e_1_2_9_1_53_1 doi: 10.1038/S41598‐017‐02227‐9 – ident: e_1_2_9_1_21_1 doi: 10.1042/BJ20061100 – ident: e_1_2_9_1_16_1 doi: 10.3389/fchem.2017.00005 – ident: e_1_2_9_1_27_1 doi: 10.1096/fj.201600811R – ident: e_1_2_9_1_33_1 doi: 10.1186/s12906‐015‐0940‐9 – ident: e_1_2_9_1_36_1 doi: 10.1016/j.etap.2018.07.007 – ident: e_1_2_9_1_24_1 doi: 10.1186/S12935‐018‐0646‐4 – ident: e_1_2_9_1_32_1 doi: 10.1021/acs.jmedchem.5b02016 – ident: e_1_2_9_1_52_1 doi: 10.1038/s41598‐017‐08963‐2 – ident: e_1_2_9_1_46_1 doi: 10.1016/j.ymthe.2005.03.038 – ident: e_1_2_9_1_43_1 doi: 10.2147/OTT.S100685 – ident: e_1_2_9_1_18_1 doi: 10.1002/jcp.25958 – ident: e_1_2_9_1_13_1 doi: 10.1016/j.febslet.2015.11.002 – ident: e_1_2_9_1_2_1 doi: 10.1016/j.bbamem.2016.06.025 – ident: e_1_2_9_1_10_1 doi: 10.1016/j.biomaterials.2013.10.082 – ident: e_1_2_9_1_28_1 doi: 10.1038/Srep11719 – ident: e_1_2_9_1_51_1 doi: 10.1007/s00726‐012‐1421‐9 – ident: e_1_2_9_1_11_1 doi: 10.1016/j.ijantimicag.2008.04.003 – ident: e_1_2_9_1_17_1 doi: 10.1016/j.bbamcr.2014.11.006 – ident: e_1_2_9_1_14_1 doi: 10.1007/s00726‐017‐2453‐y – ident: e_1_2_9_1_45_1 doi: 10.3390/ijms17050701 – ident: e_1_2_9_1_12_1 doi: 10.1371/journal.pone.0126390 – ident: e_1_2_9_1_54_1 doi: 10.3892/ol.2016.4601 – ident: e_1_2_9_1_47_1 doi: 10.1371/journal.pone.0063641 – ident: e_1_2_9_1_7_1 doi: 10.1371/journal.pone.0057236 – ident: e_1_2_9_1_30_1 doi: 10.3389/fnins.2017.00073 – ident: e_1_2_9_1_48_1 doi: 10.3390/bios7040057 – ident: e_1_2_9_1_38_1 doi: 10.1016/j.cbpa.2017.03.014 – ident: e_1_2_9_1_9_1 doi: 10.3892/ijo.2017.3866 – ident: e_1_2_9_1_57_1 doi: 10.1002/smll.200900520 – ident: e_1_2_9_1_50_1 doi: 10.1007/s11274‐015‐1986‐z – ident: e_1_2_9_1_19_1 doi: 10.1016/j.jinorgbio.2017.07.011 – ident: e_1_2_9_1_23_1 doi: 10.1002/tox.22568 – ident: e_1_2_9_1_34_1 doi: 10.1016/j.yexcr.2007.05.015 – ident: e_1_2_9_1_35_1 doi: 10.1158/1535‐7163.MCT‐04‐0077 – ident: e_1_2_9_1_37_1 doi: 10.1021/acsmedchemlett.5b00433 – ident: e_1_2_9_1_4_1 doi: 10.1016/j.bmcl.2013.06.005 – ident: e_1_2_9_1_56_1 doi: 10.1039/c7ob02233f – ident: e_1_2_9_1_44_1 doi: 10.2147/IJN.S109795 – ident: e_1_2_9_1_55_1 doi: 10.1093/humupd/dmu065 – ident: e_1_2_9_1_8_1 doi: 10.18632/oncotarget.22890 – ident: e_1_2_9_1_20_1 doi: 10.1155/2015/735087 – ident: e_1_2_9_1_26_1 doi: 10.1016/j.bbamem.2014.11.013 – ident: e_1_2_9_1_5_1 doi: 10.1093/emboj/cdg423 – ident: e_1_2_9_1_29_1 doi: 10.4014/jmb.1411.11058 – ident: e_1_2_9_1_49_1 doi: 10.1016/j.ejphar.2009.08.043 |
SSID | ssj0009933 |
Score | 2.4509552 |
Snippet | The anticancer activity of cationic antimicrobial peptides (AMPs) has become more interesting because some AMPs have selective recognition against cancer... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 22116 |
SubjectTerms | Anticancer properties Antimicrobial agents antimicrobial peptide Antimicrobial peptides Antitumor activity Apoptosis Atomic force microscopy Autophagy Cationic antimicrobial peptides cationic cell‐penetrating KT2 Cations Caveolae Cell death Cell membranes Cell viability Clathrin Colon Colon cancer Colorectal cancer Cytochrome c Cytochromes Cytotoxicity Defects Endocytosis Internalization Lipids Lysine Membrane permeability Membrane structure Membrane structures Membranes Peptides Phagocytosis Surface charge Toxicity Tryptophan |
Title | The cationic cell‐penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.28774 https://www.ncbi.nlm.nih.gov/pubmed/31073999 https://www.proquest.com/docview/2279774731 https://www.proquest.com/docview/2231951512 |
Volume | 234 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqSkhcoLQ8thQ0IIS4ZBsnThyLU7VQrYpACG2lHpAiv1IW2GzU7B6WEz-BEz-QX8LYTlKVh4TIyZInycSZsT-Pxt8Q8kTlnOLUqyOa5zJiivNIJiKOFJVcU_QnzdxB4ddv8ukpOznLzrbI8_4sTOCHGAJuzjP8fO0cXKr28JI09KNuxgj3ueMCpWnuePNfvLukjhJdGXmfgpAx2rMKxcnhcOfVteg3gHkVr_oF5_gmed-rGvJMPo3XKzXWX35hcfzPb9khNzogCkfBcm6RLVvvkr2jGjfhiw08BZ8a6mPuu-RaqFi52SPf0awgRPnmGlzU_8fXbw3Ol559tz6HV7MEGpcpYyw0PtXPtl4OFnaBKtYWjPUpJCBrA7JZNqtlO2_BBYRBrh3PgTzfwLz-MFc-nQyb4CsJwnQyA0pzcETbNWqB9nrhn93eJqfHL2eTadSVdoh0mqUsoqmNpWDGGoQcCFN0ViljYinT1BQmrwolKry4skIklTFJUTGpNGWZI_QrVHqHbNfL2t4jUPE4kSy1FrfUTBRCxornlY0dUZ8wOh6RZ_1PLnXHe-7Kb3wuA2NzUuLol370R-TxINoEso8_CR30llJ2_t6WjocR-3hKR-TR0I2e6gYBh3a5djI43WUOYY3I3WBhw1sQZHOEigKV9Xby99eXJ5O3vrH_76L3yXXEeSJk4RyQ7dXF2j5ALLVSD73T_ARPDh1L |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYILj5bCQoEBIcQl2zhx4ljiUq2olr6E0FbqBUV-pSyw2ajZPSwnfgInfiC_hLHzqMpDQuRkyZPYcWbsz5PxN4Q8VymnOPXqgKapDJjiPJCRCANFJdcU7Ukzd1D46Dgdn7D90-R0jbzqzsI0_BC9w81Zhp-vnYE7h_TOBWvoR10NEe9zdoVc9f_nHCR6d0EeJdpE8j4IIWG04xUKo53-1sur0W8Q8zJi9UvO3i3yvutsE2nyabhcqKH-8guP4_--zW1ys8WisNsozx2yZssNsrlb4j58toIX4KNDvdt9g1xrklauNsl31CxoHH1TDc7x_-PrtwqnTE_AW57BwSSCygXLGAuVj_aztZeDmZ1hH0sLxvooEpClAVnNq8W8ntbgfMIgl47qQJ6tYFp-mCofUYZF8MkEYTyaAKUpOK7tEnuBKnvun13fJSd7ryejcdBmdwh0nMQsoLENpWDGGkQdiFR0UihjQinj2GQmLTIlCry4skJEhTFRVjCpNGWJ4_TLVLxF1st5ae8TKHgYSRZbi7tqJjIhQ8XTwoaOq08YHQ7Iy-4r57qlPncZOD7nDWlzlOPo5370B-RZL1o1fB9_EtruVCVvTb7OHRUj1vGYDsjTvhqN1Q0CDu186WRwxkscyBqQe42K9a0gzuaIFgV21ivK35vP90dvfeHBv4s-IdfHk6PD_PDN8cFDcgNhn2iCcrbJ-uJ8aR8htFqox96CfgIM2iFp |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYgLj5bCQoEBIcQl2zhx4licqoXV0kJVoa3UA1LkV9otbDbq7h6WEz-BEz-QX8LYeVTlISFysuRJMnFm7M-j8TeEPFcppzj16oCmqQyY4jyQkQgDRSXXFP1JM3dQ-P1BOjpie8fJ8Rp51Z6FqfkhuoCb8ww_XzsHr0yxc0EaeqarPsJ9zq6QqyzFZdIhog8X3FGiqSPvcxASRltaoTDa6W69vBj9hjAvA1a_4gxvkY-trnWiyaf-cqH6-ssvNI7_-TG3yc0GicJubTp3yJotN8jmbom78OkKXoDPDfVB9w1yrS5Zudok39GuoA7zTTS4sP-Pr98qnDA9_W55AvvjCCqXKmMsVD7Xz869HEztFFUsLRjrc0hAlgZkNasWs_lkDi4iDHLpiA7kyQom5elE-XwybIIvJQijwRgoTcExbZeoBRrsuX_2_C45Gr4ZD0ZBU9sh0HESs4DGNpSCGWsQcyBO0UmhjAmljGOTmbTIlCjw4soKERXGRFnBpNKUJY7RL1PxFlkvZ6W9T6DgYSRZbC3uqZnIhAwVTwsbOqY-YXTYIy_bn5zrhvjc1d_4nNeUzVGOo5_70e-RZ51oVbN9_Elou7WUvHH4ee6IGLGPx7RHnnbd6KpuEHBoZ0sng_Nd4iBWj9yrLax7C6JsjlhRoLLeTv7--nxvcOgbD_5d9Am5fvh6mL97e7D_kNxAzCfqjJxtsr44X9pHiKsW6rH3n5-YzCAY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+cationic+cell%E2%80%90penetrating+KT2+peptide+promotes+cell+membrane+defects+and+apoptosis+with+autophagy+inhibition+in+human+HCT+116+colon+cancer+cells&rft.jtitle=Journal+of+cellular+physiology&rft.au=Maraming%2C+Pornsuda&rft.au=Klaynongsruang%2C+Sompong&rft.au=Boonsiri%2C+Patcharee&rft.au=Peng%2C+Shu%E2%80%90Fen&rft.date=2019-12-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=234&rft.issue=12&rft.spage=22116&rft.epage=22129&rft_id=info:doi/10.1002%2Fjcp.28774&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jcp_28774 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon |